L26/P-822 Association between serum progesterone on blastocyst transfer day and live birth in modified natural cycle frozen embryo transfer
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N.F. Wang und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Is progesterone on blastocyst transfer day associated with live birth rate (LBR) in modified natural cycle frozen embryo transfer (mNC-FET) without luteal phase support (LPS)? Summary answer In mNC-FET without LPS, progesterone on the day of blastocyst transfer was associated with LBR in the crude, but not in the adjusted, regression analyses. What is known already Whether LPS should be routinely administered in mNC-FET remains debated. A recent large, randomised controlled trial (RCT) found no effect of LPS on LBR. However, it is unclear whether certain subgroups, such as women with low serum progesterone on the day of blastocyst transfer, might benefit. This study examines the association between serum progesterone on transfer day and live birth in mNC-FET without LPS, to guide whether future trials of targeted LPS in women with low progesterone are warranted. Study design, size, duration The study included 677 women undergoing single, autologous blastocyst transfer in the mNC-FET protocol without LPS. Data were collected prospectively from 2019-2025 as part of two large multicenter RCTs (The FET Optimizing and FET Immediate trials). Serum progesterone was measured on the day of blastocyst transfer, either six (n = 476) or seven (n = 201) days after hCG trigger. Participants/materials, setting, methods The association between serum progesterone and live birth was assessed using crude and adjusted logistic regression models, the latter adjusting for female age, BMI, AMH, and RCT. Progesterone was analysed as both a continuous and a categorical variable. For the categorical analysis, progesterone levels were classified as ‘low’ or ‘normal–high’ based on the 25th percentile on the day of transfer. Sensitivity analyses were performed excluding mNC-FET cycles conducted in the cycle immediately after oocyte retrieval. Main results and the role of chance The mean (SD) age of included women was 33.0 (4.1) years. Serum progesterone on the day of blastocyst transfer had a median (IQR) of 38.6 (29.5-54.0) nmol/L and a mean (SD) of 44.1 (23.6) nmol/L. The 25th percentile for the whole cohort was 29.5 nmol/L, with day 6 and 7 transfer 25th percentiles at 28.1 nmol/L and 33.6 nmol/L, respectively. In crude analyses, each 1 nmol/L increase in progesterone was associated with slightly higher odds of live birth (OR 1.02, 95% CI 1.01–1.03), and patients with progesterone ≤25th percentile had lower odds of live birth than those above the 25th percentile (OR 0.59, 95% CI 0.38–0.91). After adjustment for female age, BMI, AMH, and RCT, these associations were no longer statistically significant for continuous progesterone (OR 0.99, 95% CI 0.98–1.01) or progesterone below 25th percentile versus above (OR 0.96, 95% CI 0.55–1.69). Sensitivity analyses excluding immediate cycles showed similar results. Limitations, reasons for caution Despite the large sample size, the study may be underpowered to detect small effects, and residual confounding cannot be excluded. As the study population was relatively young, the results may differ in older IVF populations and should not be extrapolated to cohorts of higher age. Wider implications of the findings These results do not support routine measurement of serum progesterone on the day of blastocyst transfer or intervention based on a specific progesterone cutoff. However, targeted LPS in selected subgroups, such as women with very low progesterone, warrants further investigation in sufficiently powered, prospective studies. Trial registration number Yes
Zitieren
APA
Wang, N., Bergenheim, S., Saupstad, M., Colombo, C., Johansen, A., Bogstad, J., Freiesleben, N., Nøhr, B., Oxlund-Mariegaard, B., Alsbjerg, B., Løkkegaard, E., Husth, M., Gabrielsen, A., Pinborg, A., & Løssl, K. (2026). L26/P-822 Association between serum progesterone on blastocyst transfer day and live birth in modified natural cycle frozen embryo transfer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1149
Vancouver
Wang N, Bergenheim S, Saupstad M, Colombo C, Johansen A, Bogstad J, et al. L26/P-822 Association between serum progesterone on blastocyst transfer day and live birth in modified natural cycle frozen embryo transfer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1149
BibTeX
@article{Wang2026,
author = {Wang, N.F. and Bergenheim, S. and Saupstad, M. and Colombo, C. and Johansen, A.S. and Bogstad, J.W. and Freiesleben, N.L.C. and Nøhr, B. and Oxlund-Mariegaard, B. and Alsbjerg, B. and Løkkegaard, E. and Husth, M. and Gabrielsen, A.V. and Pinborg, A. and Løssl, K.},
title = {L26/P-822 Association between serum progesterone on blastocyst transfer day and live birth in modified natural cycle frozen embryo transfer},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1149}
}
EUVIMED